AAV-PGIS gene transfer improves hypoxia-induced pulmonary hypertension in mice.

[1]  S. Miyachi,et al.  Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates , 2007, Neuroscience.

[2]  O. Danos,et al.  Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice , 2006, Gene Therapy.

[3]  J. Rasko,et al.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.

[4]  S. Ogawa,et al.  A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. , 2005, American journal of respiratory and critical care medicine.

[5]  S. Archer,et al.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. , 2005, The Journal of clinical investigation.

[6]  D. Stewart,et al.  Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow–Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease , 2005, Circulation research.

[7]  Bing Wang,et al.  Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart , 2005, Nature Biotechnology.

[8]  K. Okumura,et al.  Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats. , 2004, Human gene therapy.

[9]  H. Matsuda,et al.  Gene transfer of human prostacyclin synthase into the liver is effective for the treatment of pulmonary hypertension in rats. , 2002, The Journal of thoracic and cardiovascular surgery.

[10]  D. Eidelberg,et al.  Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. , 2001, Human gene therapy.

[11]  T. Ogihara,et al.  Gene Transfer of Human Prostacyclin Synthase Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats , 2000, Circulation.

[12]  N. Voelkel,et al.  Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. , 1999, The Journal of clinical investigation.

[13]  T. Flotte,et al.  Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus , 1998, The Lancet.

[14]  V. Ullrich,et al.  Molecular cloning and expression of human prostacyclin synthase. , 1994, Biochemical and biophysical research communications.

[15]  L. Rubin,et al.  Primary pulmonary hypertension. , 1997, The New England journal of medicine.

[16]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[17]  T. Tonai,et al.  Enzyme immunoassay of 6-ketoprostaglandin F1α in a solid phase , 1985 .